TR200906506A2 - Telmisartan içeren katı dozaj formları. - Google Patents

Telmisartan içeren katı dozaj formları.

Info

Publication number
TR200906506A2
TR200906506A2 TR2009/06506A TR200906506A TR200906506A2 TR 200906506 A2 TR200906506 A2 TR 200906506A2 TR 2009/06506 A TR2009/06506 A TR 2009/06506A TR 200906506 A TR200906506 A TR 200906506A TR 200906506 A2 TR200906506 A2 TR 200906506A2
Authority
TR
Turkey
Prior art keywords
dosage forms
solid dosage
forms containing
containing telmisartan
telmisartan
Prior art date
Application number
TR2009/06506A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/06506A priority Critical patent/TR200906506A2/tr
Priority to PCT/TR2010/000168 priority patent/WO2011025467A1/en
Publication of TR200906506A2 publication Critical patent/TR200906506A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, aktif ajan olarak telmisartan ve hidroklorotiazid içeren tek katmanlı oral dozaj formlarına, bu formların kompozisyonlarına ve bu dozaj formlarının hazırlanmasına yönelik usullere ilişkindir.
TR2009/06506A 2009-08-24 2009-08-24 Telmisartan içeren katı dozaj formları. TR200906506A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/06506A TR200906506A2 (tr) 2009-08-24 2009-08-24 Telmisartan içeren katı dozaj formları.
PCT/TR2010/000168 WO2011025467A1 (en) 2009-08-24 2010-08-13 Solid dosage forms comprising telmisartan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/06506A TR200906506A2 (tr) 2009-08-24 2009-08-24 Telmisartan içeren katı dozaj formları.

Publications (1)

Publication Number Publication Date
TR200906506A2 true TR200906506A2 (tr) 2011-03-21

Family

ID=43333029

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/06506A TR200906506A2 (tr) 2009-08-24 2009-08-24 Telmisartan içeren katı dozaj formları.

Country Status (2)

Country Link
TR (1) TR200906506A2 (tr)
WO (1) WO2011025467A1 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2706292A1 (en) * 2010-05-28 2011-11-28 Pharmascience Inc. A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide
CN107501192A (zh) * 2017-08-15 2017-12-22 中国科学院上海药物研究所 替米沙坦与氢氯噻嗪的共晶
CN111249243A (zh) * 2020-03-18 2020-06-09 重庆康刻尔制药有限公司 一种替米沙坦片及其制备方法
WO2025132571A1 (en) 2023-12-20 2025-06-26 Krka, D.D., Novo Mesto Immediate release monolayer tablet comprising telmisartan and one or more other antihypertensive agents, method of manufacturing the same, and its use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
CN101352421A (zh) 2002-01-16 2009-01-28 贝林格尔英格海姆法玛两合公司 一种制备基本上非结晶形式的替米沙坦的方法
US9029363B2 (en) * 2003-04-30 2015-05-12 Boehringer Ingelheim International Gmbh Telmisartan sodium salt pharmaceutical formulation
WO2006063737A1 (en) 2004-12-17 2006-06-22 Boehringer Ingelheim International Gmbh Combination therapy comprising telmisartan and hydrochlorothiazide
US20060159747A1 (en) 2004-12-17 2006-07-20 Boehringer Ingelheim International Gmbh Telmisartan and hydrochlorothiazide combination therapy
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
SI22297A (sl) * 2006-06-23 2007-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava soli telmisartana

Also Published As

Publication number Publication date
WO2011025467A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
JOP20180103A1 (ar) مركب صيدلاني
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
GEP20146197B (en) New compounds
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
UA109464C2 (uk) Спірооксіндольні антагоністи mdm2
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
PT3061454T (pt) Composições veterinárias orais parasiticidas compreendendo agentes activos de actuação sistémica, métodos e as suas utilizações
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
UA114087C2 (xx) Похідні піридину
JO3416B1 (ar) تركيبات مضادة للبكتيريا وطرق استخدامها
MX2011009847A (es) Agentes antihelminticos y su uso.
CY1118062T1 (el) Συνθεσεις για την αντιμετωπιση της ναυτιας και του εμετου κεντρικης προελευσης
MX2011003473A (es) Composiciones para el cuidado bucal.
MY153805A (en) Nicotine containing soft gelatin pastilles
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MX2011012993A (es) Bencimidazoles, benzotiazoles y benzoxazoles, sustituidos.
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
MX2013006418A (es) Derivados de oxazolil-metileter como agonistas del receptor de alx.
EA201290229A1 (ru) Производные спиролактама и их применение
BR122020011180B8 (pt) formulações injetáveis de compostos de tetraciclina
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
TR200906506A2 (tr) Telmisartan içeren katı dozaj formları.